Annual CFF
$4.52 M
-$1.02 M-18.48%
December 31, 2023
Summary
- As of February 10, 2025, CGTX annual cash flow from financing activities is $4.52 million, with the most recent change of -$1.02 million (-18.48%) on December 31, 2023.
- During the last 3 years, CGTX annual CFF has fallen by -$1.24 million (-21.58%).
- CGTX annual CFF is now -91.50% below its all-time high of $53.20 million, reached on December 31, 2021.
Performance
CGTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$329.00 K
+$467.00 K+338.41%
September 30, 2024
Summary
- As of February 10, 2025, CGTX quarterly cash flow from financing activities is $329.00 thousand, with the most recent change of +$467.00 thousand (+338.41%) on September 30, 2024.
- Over the past year, CGTX quarterly CFF has increased by +$332.00 thousand (+11066.67%).
- CGTX quarterly CFF is now -99.29% below its all-time high of $46.36 million, reached on December 31, 2021.
Performance
CGTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$14.62 M
+$332.00 K+2.32%
September 30, 2024
Summary
- As of February 10, 2025, CGTX TTM cash flow from financing activities is $14.62 million, with the most recent change of +$332.00 thousand (+2.32%) on September 30, 2024.
- Over the past year, CGTX TTM CFF has increased by +$7.40 million (+102.42%).
- CGTX TTM CFF is now -72.51% below its all-time high of $53.20 million, reached on December 31, 2021.
Performance
CGTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CGTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.5% | +10000.0% | +102.4% |
| 3 y3 years | -21.6% | +10000.0% | +102.4% |
| 5 y5 years | +61.8% | +10000.0% | +102.4% |
CGTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -91.5% | at low | -99.3% | +188.0% | -72.5% | +223.4% |
| 5 y | 5-year | -91.5% | +61.8% | -99.3% | +128.5% | -72.5% | +286.6% |
| alltime | all time | -91.5% | +61.8% | -99.3% | +128.5% | -72.5% | +286.6% |
Cognition Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $329.00 K(-338.4%) | $14.62 M(+2.3%) |
| Jun 2024 | - | -$138.00 K(-101.2%) | $14.29 M(-13.5%) |
| Mar 2024 | - | $11.99 M(+391.7%) | $16.52 M(+265.5%) |
| Dec 2023 | $4.52 M(-18.5%) | $2.44 M(<-9900.0%) | $4.52 M(-37.4%) |
| Sep 2023 | - | -$3000.00(-100.1%) | $7.22 M(-10.8%) |
| Jun 2023 | - | $2.10 M(<-9900.0%) | $8.10 M(+43.9%) |
| Mar 2023 | - | -$10.00 K(-100.2%) | $5.63 M(+1.5%) |
| Dec 2022 | $5.55 M | $5.14 M(+491.7%) | $5.55 M(-88.1%) |
| Sep 2022 | - | $869.00 K(-332.4%) | $46.77 M(+4.1%) |
| Jun 2022 | - | -$374.00 K(+311.0%) | $44.94 M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$91.00 K(-100.2%) | $44.15 M(-17.0%) |
| Dec 2021 | $53.20 M(+822.8%) | $46.36 M(-4924.2%) | $53.20 M(+630.3%) |
| Sep 2021 | - | -$961.00 K(-16.8%) | $7.29 M(-13.1%) |
| Jun 2021 | - | -$1.16 M(-112.9%) | $8.38 M(-23.4%) |
| Mar 2021 | - | $8.96 M(+1912.6%) | $10.94 M(+89.7%) |
| Dec 2020 | $5.76 M(+106.3%) | $445.00 K(+222.5%) | $5.76 M(+8.4%) |
| Sep 2020 | - | $138.00 K(-90.1%) | $5.32 M(+2.7%) |
| Jun 2020 | - | $1.40 M(-63.0%) | $5.18 M(+37.0%) |
| Mar 2020 | - | $3.78 M | $3.78 M |
| Dec 2019 | $2.79 M | - | - |
FAQ
- What is Cognition Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Cognition Therapeutics?
- What is Cognition Therapeutics annual CFF year-on-year change?
- What is Cognition Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly CFF year-on-year change?
- What is Cognition Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cognition Therapeutics?
- What is Cognition Therapeutics TTM CFF year-on-year change?
What is Cognition Therapeutics annual cash flow from financing activities?
The current annual CFF of CGTX is $4.52 M
What is the all time high annual CFF for Cognition Therapeutics?
Cognition Therapeutics all-time high annual cash flow from financing activities is $53.20 M
What is Cognition Therapeutics annual CFF year-on-year change?
Over the past year, CGTX annual cash flow from financing activities has changed by -$1.02 M (-18.48%)
What is Cognition Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CGTX is $329.00 K
What is the all time high quarterly CFF for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly cash flow from financing activities is $46.36 M
What is Cognition Therapeutics quarterly CFF year-on-year change?
Over the past year, CGTX quarterly cash flow from financing activities has changed by +$332.00 K (+11066.67%)
What is Cognition Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CGTX is $14.62 M
What is the all time high TTM CFF for Cognition Therapeutics?
Cognition Therapeutics all-time high TTM cash flow from financing activities is $53.20 M
What is Cognition Therapeutics TTM CFF year-on-year change?
Over the past year, CGTX TTM cash flow from financing activities has changed by +$7.40 M (+102.42%)